Wolverine Asset Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Wolverine Asset Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,283	Closed	-$850K	–	2071
2023 Q1	$850K	Buy	+35,283	New	+$443K	0.01%	726

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wolverine Asset Management's PRVB Position: Q2 2023 in Review

Wolverine Asset Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 35,283 shares — an estimated $850K sold.

Wolverine Asset Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $850K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Wolverine Asset Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 35,283 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $850K.
Wolverine Asset Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Wolverine Asset Management's Provention Bio, Inc. Common Stock position peaked at $850K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.